因专利纠纷，苹果暂停销售 Apple Watch Series 9 和 Ultra 2

湾里湾外汇编：根据最新的一份声明，苹果将于 12 月 21 日暂停 Apple Watch Ultra 2 和 Apple Watch Series 9 在官网的销售，并在 12 月 24 日后进一步暂停这些机型在线下零售店的销售。起因则是今年 10 月份 ITC（国际贸易委员会）做出的一项裁决，涉及到苹果和医疗技术公司 Masimo 之间关于 SpO2 传感器的专利纠纷。

需要注意的是，已销售的 Apple Watch 相关的血氧监测服务不会受到影响，而未搭载该传感器的 Apple Watch SE 也将正常销售。

△ Apple Watch Ultra 2，图源：DigitalTrends

以下为苹果声明全文：

A Presidential Review Period is in progress regarding an order from the U.S. International Trade Commission on a technical intellectual property dispute pertaining to Apple Watch devices containing the Blood Oxygen feature. While the review period will not end until December 25, Apple is preemptively taking steps to comply should the ruling stand. This includes pausing sales of the Apple Watch Series 9 and Apple Watch Ultra 2 from Apple.com starting December 21, and from Apple retail locations after December 24.

Apple’s teams work tirelessly to create products and services that empower users with industry-leading health, wellness, and safety features. Apple strongly disagrees with the order and is pursuing a range of legal and technical options to ensure that Apple Watch is available to customers.

Should the order stand, Apple will continue to take all measures to return Apple Watch Series 9 and Apple Watch Ultra 2 to customers in the U.S. as soon as possible.